Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Dow
Argus Health
Medtronic
Julphar
Citi
Moodys
Baxter
Cipla

Generated: November 17, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Glembatumumab vedotin

« Back to Dashboard

US Patents for Glembatumumab vedotin

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Glembatumumab vedotin ➤ Try a Free Trial P97 fragments with transfer activity biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) ➤ Try a Free Trial
Glembatumumab vedotin ➤ Try a Free Trial Fragments of p97 and uses thereof biOasis Technologies, Inc. (Richmond, CA) ➤ Try a Free Trial
Glembatumumab vedotin ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Glembatumumab vedotin ➤ Try a Free Trial Methods and compositions for infusion of transiently engrafting, selected populations of allogeneic lymphocytes to treat cancer The Johns Hopkins University (Baltimore, MD) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Glembatumumab vedotin

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Glembatumumab vedotin Australia 2012294673 2031-08-05 ➤ Try a Free Trial
Glembatumumab vedotin Canada 2842492 2031-08-05 ➤ Try a Free Trial
Glembatumumab vedotin Denmark 2739649 2031-08-05 ➤ Try a Free Trial
Glembatumumab vedotin European Patent Office 2739649 2031-08-05 ➤ Try a Free Trial
Glembatumumab vedotin European Patent Office 3321281 2031-08-05 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
US Department of Justice
Accenture
Federal Trade Commission
Moodys
Healthtrust
US Army
Farmers Insurance
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: